Clinical Trials Directory

Trials / Completed

CompletedNCT03637192

Acute Exposure of High Altitude on Cognitive Function

Acute Exposure to Hypoxia in Precapillary Pulmonary Hypertension: Physiological and Clinical Effects at Rest and During Exercise

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Randomized crossover Trial in patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary Hypertension (CTEPH) to assess the acute response to High Altitude (2500m above sea level) on cognitive functions

Detailed description

Low altitude baseline measurements will be performed in Zurich (460m) including Echocardiography, Right heart catheterization, 6 Minute walk test, pulmonary function test, clinical assessment and blood gas analysis. Randomly assigned to the order of testing, the participants will be tested in Low Altitude (Zurich, 470m) and at High Altitude (2500m). During the exposure to High Altitude (Säntis; 2500m above sea level) for approximately 5 hour, the participants will perform cognitive function test . The results will be compared to low altitude in Zurich (470m).

Conditions

Interventions

TypeNameDescription
OTHERLow altitude: 470m above sea levelAssessment at Low Altitude (in Zurich; 470m above sea level) in order to compare this data with High altitude exposure
OTHERSäntis; 2500m above sea LevelExposure to High Altitude (Säntis; 2500m above sea level) for approximately 5 hours

Timeline

Start date
2018-07-01
Primary completion
2019-01-01
Completion
2019-01-01
First posted
2018-08-17
Last updated
2020-01-07

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03637192. Inclusion in this directory is not an endorsement.